Bank of Montreal Can cut its holdings in AngioDynamics, Inc. (NASDAQ:ANGO) by 68.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 59,032 shares of the medical instruments supplier’s stock after selling 128,602 shares during the quarter. Bank of Montreal Can’s holdings in AngioDynamics were worth $981,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of ANGO. SG Americas Securities LLC bought a new stake in AngioDynamics in the third quarter worth about $143,000. Trexquant Investment LP acquired a new stake in AngioDynamics during the 3rd quarter worth about $175,000. Teachers Retirement System of The State of Kentucky raised its holdings in AngioDynamics by 54.9% during the 2nd quarter. Teachers Retirement System of The State of Kentucky now owns 11,000 shares of the medical instruments supplier’s stock worth $178,000 after buying an additional 3,900 shares during the period. Thrivent Financial For Lutherans raised its holdings in AngioDynamics by 13.4% during the 2nd quarter. Thrivent Financial For Lutherans now owns 20,610 shares of the medical instruments supplier’s stock worth $334,000 after buying an additional 2,430 shares during the period. Finally, BNP Paribas Arbitrage SA raised its holdings in AngioDynamics by 50.9% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 21,329 shares of the medical instruments supplier’s stock worth $365,000 after buying an additional 7,194 shares during the period. Hedge funds and other institutional investors own 94.55% of the company’s stock.
Shares of AngioDynamics, Inc. (ANGO) opened at $16.54 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.65 and a current ratio of 2.56. The stock has a market capitalization of $603.36, a PE ratio of -78.76, a price-to-earnings-growth ratio of 1.52 and a beta of 0.98. AngioDynamics, Inc. has a twelve month low of $14.80 and a twelve month high of $18.85.
ANGO has been the topic of several recent analyst reports. BidaskClub downgraded AngioDynamics from a “hold” rating to a “sell” rating in a report on Saturday, January 6th. Zacks Investment Research upgraded AngioDynamics from a “hold” rating to a “buy” rating and set a $19.00 price objective on the stock in a report on Monday, January 22nd. TheStreet downgraded AngioDynamics from a “b-” rating to a “c” rating in a report on Tuesday, January 2nd. Finally, Craig Hallum downgraded AngioDynamics from a “buy” rating to a “hold” rating in a report on Friday, January 5th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. AngioDynamics has a consensus rating of “Hold” and an average price target of $18.60.
ILLEGAL ACTIVITY WARNING: This report was reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2018/02/18/bank-of-montreal-can-reduces-holdings-in-angiodynamics-inc-ango.html.
AngioDynamics Company Profile
AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.
Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).
Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.